(NLDO) - Due to false declarations leading to a lack of tax payable, a "big guy" in the medical equipment supply industry has been heavily fined.
Vietnam - Japan Medical Investment and Development Joint Stock Company (stock code: JVC) has just announced the decision to impose administrative penalties on tax violations by the Hanoi Tax Department.
Specifically, this enterprise has committed the act of declaring input value-added tax on invoices for purchasing goods and services of units that have left their business addresses; incorrectly declaring revenue and output value-added tax; incorrectly declaring adjustment targets; under-allocating non-deductible input value-added tax for revenue not subject to value-added tax...
In addition, this company also declared the cost of purchasing goods and services from units that had abandoned their business addresses; recorded the cost of pre-deducting the amount payable to employees but in reality did not spend all of it; recorded the payment to shareholders contributing capital (including principal and interest) in the operating costs of the association during the period not in accordance with regulations...
This company is distributing many modern products in the medical field.
Based on the act of false declaration leading to a lack of tax payable, the Hanoi Tax Department fined Viet Nhat Medical Investment and Development Joint Stock Company more than 1.9 billion VND. Along with that, the company was also charged with unpaid tax plus late payment fees of nearly 11 billion VND.
The total amount of tax arrears, fines and late payment fees of this enterprise is more than 12.8 billion VND.
In the market, Viet Nhat Medical Investment and Development Company is considered a "big guy" in the medical equipment supply industry when distributing diagnostic imaging technology products and machinery for modern operating rooms in Vietnam.
This enterprise has cooperated with many large hospitals across the country such as Bach Mai Hospital, Viet Duc Friendship Hospital, K Hospital...
In 2024, Viet Nhat Medical Investment and Development Company recorded a slight decrease in after-tax profit of 1.5% over the same period, to VND 52 billion, although net revenue increased by more than 6%, reaching VND 612.5 billion.
Closing the trading session on March 3, JVC shares were at VND 4,600/share, unchanged from the previous day but up more than 21% compared to the beginning of 2025.
Source: https://nld.com.vn/doanh-nghiep-chuyen-ban-thiet-bi-y-te-bi-truy-thu-va-phat-thue-gan-13-ti-dong-196250303213447871.htm
Comment (0)